The Early Outcomes of Nurse Case Management in Patients with Acute Ischemic Stroke Treated with Intravenous Recombinant Tissue Plasminogen Activator: A Prospective Randomized Controlled Trial
Table 2
Baseline characteristics.
Characteristics
Experimental group
Control group
p-value
Number (38)
%
Number (38)
%
Gender
Male
30
78.95
24
63.16
.508
Female
8
21.05
14
36.84
Age
< 50
4
10.52
6
15.78
.598
50-59
10
26.32
10
26.32
>60
24
63.16
22
57.9
Risk factors
Hypertension
29
76.32
29
76.32
.365
Dyslipidemia
17
44.74
17
44.74
Diabetes
13
34.21
12
31.58
Atrial fibrillation
12
31.58
12
31.58
Previous TIA
1
2.63
0
0
Smoking
15
39.47
12
31.58
Clinical presentation
Hemiparesis/paresthesia
35
92.1
37
97.37
.756
Speech disorders
20
52.63
22
57.89
Facial weakness
14
36.84
14
36.84
Vertigo/imbalance
1
2.63
0
0
Subtype of infarct
Lacunar infarct
19
50
19
50
1.0
Nonlacunar infarct
19
50
19
50
Dispatch
Self-dispatch
23
60.53
20
52.63
.549
Interhospital
15
39.47
18
47.37
EMS
0
0
0
0
TIA = transient ischemic attack and EMS = emergency medical service.
